83 related articles for article (PubMed ID: 23420501)
1. Predicting drug-target interactions through integrative analysis of chemogenetic assays in yeast.
Heiskanen MA; Aittokallio T
Mol Biosyst; 2013 Apr; 9(4):768-79. PubMed ID: 23420501
[TBL] [Abstract][Full Text] [Related]
2. Chemical-genetic approaches for exploring the mode of action of natural products.
Lopez A; Parsons AB; Nislow C; Giaever G; Boone C
Prog Drug Res; 2008; 66():237, 239-71. PubMed ID: 18416308
[TBL] [Abstract][Full Text] [Related]
3. Synthetic genetic array (SGA) analysis in Saccharomyces cerevisiae and Schizosaccharomyces pombe.
Baryshnikova A; Costanzo M; Dixon S; Vizeacoumar FJ; Myers CL; Andrews B; Boone C
Methods Enzymol; 2010; 470():145-79. PubMed ID: 20946810
[TBL] [Abstract][Full Text] [Related]
4. Chemical-genomic profiling: systematic analysis of the cellular targets of bioactive molecules.
Andrusiak K; Piotrowski JS; Boone C
Bioorg Med Chem; 2012 Mar; 20(6):1952-60. PubMed ID: 22261022
[TBL] [Abstract][Full Text] [Related]
5. Exploring gene function and drug action using chemogenomic dosage assays.
Ericson E; Hoon S; St Onge RP; Giaever G; Nislow C
Methods Enzymol; 2010; 470():233-55. PubMed ID: 20946813
[TBL] [Abstract][Full Text] [Related]
6. High-resolution chemical dissection of a model eukaryote reveals targets, pathways and gene functions.
Hoepfner D; Helliwell SB; Sadlish H; Schuierer S; Filipuzzi I; Brachat S; Bhullar B; Plikat U; Abraham Y; Altorfer M; Aust T; Baeriswyl L; Cerino R; Chang L; Estoppey D; Eichenberger J; Frederiksen M; Hartmann N; Hohendahl A; Knapp B; Krastel P; Melin N; Nigsch F; Oakeley EJ; Petitjean V; Petersen F; Riedl R; Schmitt EK; Staedtler F; Studer C; Tallarico JA; Wetzel S; Fishman MC; Porter JA; Movva NR
Microbiol Res; 2014; 169(2-3):107-20. PubMed ID: 24360837
[TBL] [Abstract][Full Text] [Related]
7. Refining current knowledge on the yeast FLR1 regulatory network by combined experimental and computational approaches.
Teixeira MC; Dias PJ; Monteiro PT; Sala A; Oliveira AL; Freitas AT; Sá-Correia I
Mol Biosyst; 2010 Dec; 6(12):2471-81. PubMed ID: 20938527
[TBL] [Abstract][Full Text] [Related]
8. Network-assisted target identification for haploinsufficiency and homozygous profiling screens.
Wang S; Peng J
PLoS Comput Biol; 2017 Jun; 13(6):e1005553. PubMed ID: 28574983
[TBL] [Abstract][Full Text] [Related]
9. Genetic Screens for Determination of Mechanism of Action.
Gay-Andrieu F; Alex D; Calderone R
Methods Mol Biol; 2016; 1356():165-72. PubMed ID: 26519072
[TBL] [Abstract][Full Text] [Related]
10. Systematic quantification of gene interactions by phenotypic array analysis.
Hartman JL; Tippery NP
Genome Biol; 2004; 5(7):R49. PubMed ID: 15239834
[TBL] [Abstract][Full Text] [Related]
11. Yeast chemical genomics and drug discovery: an update.
Hoon S; St Onge RP; Giaever G; Nislow C
Trends Pharmacol Sci; 2008 Oct; 29(10):499-504. PubMed ID: 18755517
[TBL] [Abstract][Full Text] [Related]
12. Array-based synthetic genetic screens to map bacterial pathways and functional networks in Escherichia coli.
Babu M; Gagarinova A; Emili A
Methods Mol Biol; 2011; 781():99-126. PubMed ID: 21877280
[TBL] [Abstract][Full Text] [Related]
13. Gene function prediction from synthetic lethality networks via ranking on demand.
Lippert C; Ghahramani Z; Borgwardt KM
Bioinformatics; 2010 Apr; 26(7):912-8. PubMed ID: 20154010
[TBL] [Abstract][Full Text] [Related]
14. Small fitness effects and weak genetic interactions between deleterious mutations in heterozygous loci of the yeast Saccharomyces cerevisiae.
Szafraniec K; Wloch DM; Sliwa P; Borts RH; Korona R
Genet Res; 2003 Aug; 82(1):19-31. PubMed ID: 14621268
[TBL] [Abstract][Full Text] [Related]
15. MOSAIC: a chemical-genetic interaction data repository and web resource for exploring chemical modes of action.
Nelson J; Simpkins SW; Safizadeh H; Li SC; Piotrowski JS; Hirano H; Yashiroda Y; Osada H; Yoshida M; Boone C; Myers CL
Bioinformatics; 2018 Apr; 34(7):1251-1252. PubMed ID: 29206899
[TBL] [Abstract][Full Text] [Related]
16. Analysis of gene networks for drug target discovery and validation.
Imoto S; Tamada Y; Savoie CJ; Miyano S
Methods Mol Biol; 2007; 360():33-56. PubMed ID: 17172724
[TBL] [Abstract][Full Text] [Related]
17. Combining functional genomics and chemical biology to identify targets of bioactive compounds.
Ho CH; Piotrowski J; Dixon SJ; Baryshnikova A; Costanzo M; Boone C
Curr Opin Chem Biol; 2011 Feb; 15(1):66-78. PubMed ID: 21093351
[TBL] [Abstract][Full Text] [Related]
18. Quantitative maps of genetic interactions in yeast - comparative evaluation and integrative analysis.
Lindén RO; Eronen VP; Aittokallio T
BMC Syst Biol; 2011 Mar; 5():45. PubMed ID: 21435228
[TBL] [Abstract][Full Text] [Related]
19. Genomic profiling of drug sensitivities via induced haploinsufficiency.
Giaever G; Shoemaker DD; Jones TW; Liang H; Winzeler EA; Astromoff A; Davis RW
Nat Genet; 1999 Mar; 21(3):278-83. PubMed ID: 10080179
[TBL] [Abstract][Full Text] [Related]
20. Exploring genetic interactions and networks with yeast.
Boone C; Bussey H; Andrews BJ
Nat Rev Genet; 2007 Jun; 8(6):437-49. PubMed ID: 17510664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
